pISSN 1226-6051
eISSN 2508-786X

Table. 1.

Table. 1.

Eligibility criteria for medication management in long-term care facilities in the reference countries

Country Eligibility criteria
Australia The Referring Medical Professional confirms that there is an identifiable clinical need for the Patient to have a RMMR Service
- A permanent resident of an Aged Care Facility
When the Patient's GP considers a subsequent review, for example, if there has been a significant change to the Patient's condition or medication regimen
- Discharge from hospital in the previous four weeks
- Significant change to medication regimen in the past three months - Change in medical condition or abilities (including falls, cognition, physical function)
- Prescription of a medicine with a narrow therapeutic index or requiring therapeutic monitoring
- Presentation of symptoms suggestive of an adverse drug reaction
- Suspected non-compliance or problems with managing medication related devices
Canada (Ontario) - a resident of Ontario and living in a licensed Long-Term Care Home (within 4-6 weeks of their admission)
- taking a minimum of three prescription medications for a chronic condition
- a physician’s referral or as a pharmacist’s decision, and/or as a result of specific resident criteria identified by a member of the health care team
Japan - a resident living in long-term care facility by a physician’s referral
- Pharmacists, facility nurses, caregivers, and guardians can recommend the review to the physicians
United Kingdom (UK) - a resident living in care homes
- with complex and problematic polypharmacy, specifically those on 10 or more medications - on medicines commonly associated with medication errors
- with severe frailty who are particularly isolated or housebound or who have had recent hospital admissions and/or falls
- using potentially addictive pain management medication
United States of America (USA) A resident living in long-term care facilities
Korean Pilot Project for Polypharmacy Management - Taking 10 or more medications in the past 6 months
- Taking 5 or more medication including high-risk medication in the past 6 months
Korean J Clin Pharm 2022;32:260-9 https://doi.org/10.24304/kjcp.2022.32.3.260
© 2022 Korean J Clin Pharm